Trade-Ideas: ZIOPHARM Oncology (ZIOP) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified ZIOPHARM Oncology (ZIOP) as a "perilous reversal" (up big yesterday but down big today) candidate
By TheStreet Wire ,

Trade-Ideas LLC identified

ZIOPHARM Oncology

(

ZIOP

) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified ZIOPHARM Oncology as such a stock due to the following factors:

  • ZIOP has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $14.3 million.
  • ZIOP has traded 68,720 shares today.
  • ZIOP is down 3.2% today.
  • ZIOP was up 8.6% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in ZIOP with the Ticky from Trade-Ideas. See the FREE profile for ZIOP NOW at Trade-Ideas

More details on ZIOP:

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of cancer therapies that address unmet medical needs through synthetic immuno-oncology.

The average volume for ZIOPHARM Oncology has been 2.6 million shares per day over the past 30 days. ZIOPHARM Oncology has a market cap of $902.3 million and is part of the health care sector and drugs industry. The stock has a beta of 2.41 and a short float of 31.9% with 15.11 days to cover. Shares are down 15.8% year-to-date as of the close of trading on Monday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Loading ...